<WIRE> Willem Blijdorp to Step Down as Chairperson of Clinuvel Pharmaceuticals (ASX:CUV) Board

Friday, 29 September 2023

Clinuvel Pharmaceuticals (ASX:CUV) has announced that Willem Blijdorp will step down as the Chairperson of its board of directors.

The effective date for this change will be January 1, 2024.

The board has begun a review process, following which a new chairperson will be announced.

Clinuvel Pharmaceuticals is a globally operating pharmaceutical company focusing on developing drugs for a range of severe genetic and skin disorders.

Supported by

<SPON> Trade share CFDs with Plus500

Apr 4, 2022

Global online trading services company, Plus500:

Plus500 trading platform allows you to trade shares from all popular markets such as USA, UK, Germany and more, with leverage and low spreads. Using our advanced trading tools, you can also control your profits and losses.

Plus500AU Pty Ltd, AFSL #417727 issued by Australian Securities and Investments Commission. Based in Sydney.

LINK

Subscribe to the newsletter

Receive whispers every day in your inbox.